v3.26.3
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development $ 4,535 $ 6,136 $ 18,794 $ 38,123
General and administrative 4,428 2,809 10,291 9,736
Restructuring and asset impairment charges, net (2,044)   3,033  
Total operating expenses 6,919 8,945 32,118 47,859
Loss from operations (6,919) (8,945) (32,118) (47,859)
Other income, net 73 321 584 1,451
Net loss $ (6,846) $ (8,624) $ (31,534) $ (46,408)
Net loss per common share        
Basic (in dollars per share) $ (1.29) $ (3.22) $ (5.97) $ (18.84)
Diluted (in dollars per share) $ (1.29) $ (3.22) $ (5.97) $ (18.84)
Weighted average shares outstanding        
Basic (in shares) 5,309,754 2,676,116 5,286,453 2,462,821
Diluted (in shares) 5,309,754 2,676,116 5,286,453 2,462,821
Comprehensive loss:        
Net loss $ (6,846) $ (8,624) $ (31,534) $ (46,408)
Unrealized gain (loss) on marketable securities 3 24 (21) 13
Total comprehensive loss $ (6,843) $ (8,600) $ (31,555) $ (46,395)